These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27611972)

  • 21. Slco2a1 deficiency exacerbates experimental colitis via inflammasome activation in macrophages: a possible mechanism of chronic enteropathy associated with SLCO2A1 gene.
    Nakata R; Nakamura Y; Hosomi S; Okuda H; Nishida Y; Sugita N; Itani S; Nadatani Y; Otani K; Tanaka F; Kamata N; Taira K; Nagami Y; Tanigawa T; Watanabe T; Yamagami H; Nakanishi T; Fujiwara Y
    Sci Rep; 2020 Mar; 10(1):4883. PubMed ID: 32184453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sacral Nerve Stimulation Alleviates Intestinal Inflammation Through Regulating the Autophagy of Macrophages and Activating the Inflammasome Mediated by a Cholinergic Antiinflammatory Pathway in Colitis Rats.
    Zhang S; Zhang C; Yan H; Yang L; Shi N; Liu C; Chen Y
    Neuromodulation; 2024 Feb; 27(2):302-311. PubMed ID: 36740464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timosaponin BⅡ reduces colonic inflammation and alleviates DSS-induced ulcerative colitis by inhibiting NLRP3.
    Feng M; Zhou Y; Gao Z; Huang W; Xie W; Xie W; Liu Z; Tang S; Xiong X; Chen Y; Zhou X; Liu C
    J Ethnopharmacol; 2024 May; 325():117885. PubMed ID: 38331123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone.
    Wu XF; Ouyang ZJ; Feng LL; Chen G; Guo WJ; Shen Y; Wu XD; Sun Y; Xu Q
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):146-56. PubMed ID: 25448682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation.
    Mai CT; Wu MM; Wang CL; Su ZR; Cheng YY; Zhang XJ
    Mol Immunol; 2019 Jan; 105():76-85. PubMed ID: 30496979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
    Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis
    Ma X; Di Q; Li X; Zhao X; Zhang R; Xiao Y; Li X; Wu H; Tang H; Quan J; Wu Z; Xiao W; Chen W
    Front Immunol; 2022; 13():853194. PubMed ID: 35865528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation.
    Wang L; Yu Z; Wei C; Zhang L; Song H; Chen B; Yang Q
    Oncotarget; 2017 May; 8(20):32937-32945. PubMed ID: 28380426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14.
    Liu Q; Jiao L; Ye MS; Ma Z; Yu J; Su LY; Zou WY; Yang LX; Chen C; Yao YG
    Cell Mol Immunol; 2024 Jun; 21(6):561-574. PubMed ID: 38570588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway.
    Liu Q; Zuo R; Wang K; Nong FF; Fu YJ; Huang SW; Pan ZF; Zhang Y; Luo X; Deng XL; Zhang XX; Zhou L; Chen Y
    Acta Pharmacol Sin; 2020 Jun; 41(6):771-781. PubMed ID: 31937929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginsenoside Rd ameliorates colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation in mice.
    Liu C; Wang J; Yang Y; Liu X; Zhu Y; Zou J; Peng S; Le TH; Chen Y; Zhao S; He B; Mi Q; Zhang X; Du Q
    Biochem Pharmacol; 2018 Sep; 155():366-379. PubMed ID: 30012462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium channel in a mouse model of colitis.
    Zeng B; Huang Y; Chen S; Xu R; Xu L; Qiu J; Shi F; Liu S; Zha Q; Ouyang D; He X
    Cell Mol Immunol; 2022 Aug; 19(8):925-943. PubMed ID: 35799057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CP-25 exerts therapeutic effects in mice with dextran sodium sulfate-induced colitis by inhibiting GRK2 translocation to downregulate the TLR4-NF-κB-NLRP3 inflammasome signaling pathway in macrophages.
    Li Y; Jiang MY; Chen JY; Xu ZW; Zhang JW; Li T; Zhang LL; Wei W
    IUBMB Life; 2021 Dec; 73(12):1406-1422. PubMed ID: 34590407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
    Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis.
    He X; Wei Z; Wang J; Kou J; Liu W; Fu Y; Yang Z
    Sci Rep; 2016 Jun; 6():28370. PubMed ID: 27321991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages.
    Filardy AA; He J; Bennink J; Yewdell J; Kelsall BL
    Mucosal Immunol; 2016 Jul; 9(4):850-8. PubMed ID: 26627461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
    Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
    J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.
    Zhu H; Xiao F; Xiao Y; Guo Y; Shan X; Zhang Z; Zhang L; Guo H
    J Neuroinflammation; 2023 Dec; 20(1):304. PubMed ID: 38110963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages.
    Karasawa T; Kawashima A; Usui-Kawanishi F; Watanabe S; Kimura H; Kamata R; Shirasuna K; Koyama Y; Sato-Tomita A; Matsuzaka T; Tomoda H; Park SY; Shibayama N; Shimano H; Kasahara T; Takahashi M
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):744-756. PubMed ID: 29437575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.